Regenerative medicine specialist CTIBiotech has partnered with pharmaceutical firm Gattefossé to develop 3D bioprinted skin chips that enable the patient-specific modeling of skin diseases. By a…
Prellis Biologics 3D bioprints lymph node to unlock antibody discovery at pace
Biotechnology firm Prellis Biologics has announced the closure of a $14.5 million Series B funding round alongside the creation of a novel antibody discovery platform. Effectively a functioning …
CTIBIOTECH develops novel 3D bioprinting platform to treat colon cancer
Regenerative medicine firm CTIBIOTECH has developed a new 3D bioprinting platform to deliver personalized medicine for patients with colorectal cancer. Developed in partnership with the Medical Univer…